Real time insider trading transaction history:
- Insiders are prohibited from making short-swing profits by trading their shares within 6 months of the registration or acquiring the shares.
- Shares are not adjusted for stock split.
"Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise"
- Peter Lynch
What is insider trading>>
- Peter Lynch
What is insider trading>>
Common stock purchase or sale:
| Transaction Date |
Reported DateTime |
Company | Symbol | Insider Relationship |
Shares Traded |
Average Price |
Total Amount |
Shares Owned |
Filing |
| 2022-10-13 Sale |
2022-10-13 11:03 am |
COVETRUS INC. | CVET | FONTEYNE PAUL R. Director |
13,275 | $0 | $0 | 0 (Direct) |
View |
| 2022-01-06 Purchase |
2022-01-10 8:37 pm |
Amylyx Pharmaceuticals Inc. | AMLX | FONTEYNE PAUL R. Director |
3,947 | $19 | $74,993 | 12,347 (Direct) |
View |
| 2021-08-10 Purchase |
2021-08-11 4:09 pm |
COVETRUS INC. | CVET | FONTEYNE PAUL R. Director |
5,000 | $23.24 | $116,200 | 5,000 (Direct) |
View |
| 2020-11-16 Sale |
2020-11-17 3:40 pm |
AMAG PHARMACEUTICALS INC. | AMAG | FONTEYNE PAUL R. Director |
14,676 | $0 | $0 | 0 (Direct) |
View |
| 2020-05-08 Purchase |
2020-05-12 5:53 pm |
Apellis Pharmaceuticals Inc. | APLS | FONTEYNE PAUL R. Director |
5,000 | $31.81 | $159,034 | 5,000 (Direct) |
View |
Stock options: Exercise, Award, Grant, Conversion
| Transaction Date |
Reported DateTime |
Exercisable Expiration |
Company | Symnbol | Insider Relationship |
Shares Traded |
Conversion Price |
Shares Owned |
Filing |
| 2025-01-01 Option Award |
2025-01-03 4:19 pm |
N/A 2032-12-31 |
Apellis Pharmaceuticals Inc. | APLS | FONTEYNE PAUL R. Director |
17,466 | $0 | 33,904 (Direct) |
View |
| 2024-06-06 Option Award |
2024-06-07 4:52 pm |
N/A 2034-06-05 |
Amylyx Pharmaceuticals Inc. | AMLX | FONTEYNE PAUL R. Director |
25,000 | $0 | 25,000 (Direct) |
View |
| 2024-01-01 Option Award |
2024-01-02 4:13 pm |
N/A N/A |
Apellis Pharmaceuticals Inc. | APLS | FONTEYNE PAUL R. Director |
3,341 | $0 | 22,186 (Direct) |
View |
| 2024-01-01 Option Award |
2024-01-02 4:13 pm |
N/A 2030-12-31 |
Apellis Pharmaceuticals Inc. | APLS | FONTEYNE PAUL R. Director |
5,748 | $59.86 | 22,186 (Direct) |
View |
| 2023-06-08 Option Award |
2023-06-12 7:34 pm |
N/A 2033-06-08 |
Amylyx Pharmaceuticals Inc. | AMLX | FONTEYNE PAUL R. Director |
16,985 | $0 | 16,985 (Direct) |
View |
| 2023-01-01 Option Award |
2023-01-04 5:31 pm |
N/A 2030-12-31 |
Apellis Pharmaceuticals Inc. | APLS | FONTEYNE PAUL R. Director |
11,308 | $0 | 20,538 (Direct) |
View |
| 2022-07-01 Exercise |
2022-07-06 4:06 pm |
N/A 2022-07-01 |
COVETRUS INC. | CVET | FONTEYNE PAUL R. Director |
8,275 | $0 | 13,275 (Direct) |
View |
| 2022-06-09 Option Award |
2022-06-10 4:05 pm |
N/A 2032-06-09 |
Amylyx Pharmaceuticals Inc. | AMLX | FONTEYNE PAUL R. Director |
19,000 | $0 | 19,000 (Direct) |
View |
| 2022-05-11 Option Award |
2022-05-13 4:10 pm |
N/A N/A |
COVETRUS INC. | CVET | FONTEYNE PAUL R. Director |
14,638 | $0 | 14,638 (Direct) |
View |
| 2022-05-06 Option Award |
2022-05-09 4:17 pm |
N/A N/A |
GELESIS HOLDINGS INC. | GLS | FONTEYNE PAUL R. Director |
53,832 | $0 | 53,832 (Direct) |
View |
Ownership |
2022-01-24 4:39 pm |
N/A 2027-01-13 |
GELESIS HOLDINGS INC. | GLS | FONTEYNE PAUL R. Director |
0 | $0 | 292,687 (Direct) |
View |
| 2022-01-06 Option Award |
2022-01-10 8:37 pm |
N/A 2032-01-06 |
Amylyx Pharmaceuticals Inc. | AMLX | FONTEYNE PAUL R. Director |
8,400 | $0 | 12,347 (Direct) |
View |
Ownership |
2022-01-06 5:06 pm |
N/A 2031-03-23 |
Amylyx Pharmaceuticals Inc. | AMLX | FONTEYNE PAUL R. Director |
0 | $0 | 81,100 (Direct) |
View |
| 2022-01-01 Option Award |
2022-01-04 9:28 pm |
N/A 2029-12-31 |
Apellis Pharmaceuticals Inc. | APLS | FONTEYNE PAUL R. Director |
12,784 | $0 | 17,784 (Direct) |
View |
| 2021-07-01 Option Award |
2021-07-06 4:03 pm |
N/A 2022-07-01 |
COVETRUS INC. | CVET | FONTEYNE PAUL R. Director |
8,275 | $0 | 8,275 (Direct) |
View |
| 2021-01-01 Option Award |
2021-01-04 7:31 pm |
N/A 2030-12-31 |
Apellis Pharmaceuticals Inc. | APLS | FONTEYNE PAUL R. Director |
27,600 | $0 | 27,600 (Direct) |
View |
| 2020-06-03 Option Award |
2020-06-05 4:32 pm |
N/A 2030-06-02 |
resTORbio Inc. | TORC | FONTEYNE PAUL R. Director |
14,414 | $0 | 14,414 (Direct) |
View |
| 2020-06-02 Option Award |
2020-06-04 4:49 pm |
N/A 2030-06-02 |
AMAG PHARMACEUTICALS INC. | AMAG | FONTEYNE PAUL R. Director |
31,558 | $0 | 35,965 (Direct) |
View |